Barclays analyst Lauren Lieberman lowered the firm’s price target on Clorox (CLX) to $119 from $129 and keeps an Underweight rating on the shares. The firm adjusted price targets in the staples group as a part of a Q2 preview. Investor expectations “feel subdued” into earnings season, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $135 from $140 at Citi
- Clorox price target lowered to $135 from $142 at Wells Fargo
- Musk to launch new political party, Trump threatens BRICS tariff: Morning Buzz
- Clorox using generative AI for ad creation, WSJ reports
- Clorox price target lowered to $145 from $167 at Jefferies